Home›Companies›Biotech & Pharma›Epalex

Epalex Corp.

Updated Oct 29, 2026·Latest SEC filing Nov 10, 2025·Suggest an edit

About Epalex

Epalex is a private company based in Mountain View, California. It has reported $30,756,175 raised in five offerings on Form D since November 2018. Its chief executive is Brendan Magrab.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Oct 31, 2025Nov 10, 2025$1,200,000of $3.1M target1$1.2MEquityRule 506(b)Form D ↗
Dec 9, 2024Dec 20, 2024$3,999,999of $14.9M target1$3.9MEquityRule 506(b)Form D ↗
Oct 4, 2022Oct 14, 2022$4,260,617of $8.4M target15$284KEquityRule 506(b)Form D ↗
Dec 31, 2018Jan 10, 2019amended Dec 18, 2020$20,296,275fully sold7$2.8MEquityRule 506(b)Form D/A ↗1 earlier filing
Sep 1, 2017Nov 20, 2018$999,284of $1.0M target5$199KEquityRule 506(b)Form D ↗
Total, five offerings$30,756,175

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Epalex's Form D filed Nov 10, 2025.

JS
Jon Saxe
Director
BM
Brendan Magrab
Chief Executive Officer and director
RM

Earlier filings also listed Didric Cederholm (director, last listed Dec 2024), Matthew Smith (director, last listed Oct 2022), Enrique Carrazana (director, last listed Nov 2018) and Arthur Rice (ceo and director, last listed Nov 2018).

Sources

  1. SECEPALEX Corp Form D, filed Jan 10, 2019
  2. SECEPALEX Corp filing history